Enhancer ID: | E_02_0373 |
Species: | human |
Position : | chr7:148804089-148806089 |
Biosample name: | |
Experiment class : | High+Lowthroughput |
Enhancer type: | Enhancer |
Disease: | Febrile seizures |
Pubmed ID: | 32298702 |
Enhancer experiment: | Enzyme-linked immunosorbent assay?Western blot?qRT-PCR |
Enhancer experiment description: | In addition, a significant increase in the pro-inflammatory cytokine (IL-1? and TNF-?) levels was observed in rats after GSK 126 treatment, and IL-1? administration increased seizure severity, suggesting that the inflammatory response was involved in the regulation of seizure development by EZH2. |
Target gene : | EZH2 |
Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
Less strong evidence: | RNA-Seq |
Target gene experiment description: | In addition, a significant increase in the pro-inflammatory cytokine (IL-1? and TNF-?) levels was observed in rats after GSK 126 treatment, and IL-1? administration increased seizure severity, suggesting that the inflammatory response was involved in the regulation of seizure development by EZH2. |
TF name : | -- |
TF experiment: | Enzyme-linked immunosorbent assay?Western blot?qRT-PCR |
TF experiment description: | In addition, a significant increase in the pro-inflammatory cytokine (IL-1? and TNF-?) levels was observed in rats after GSK 126 treatment, and IL-1? administration increased seizure severity, suggesting that the inflammatory response was involved in the regulation of seizure development by EZH2. |
Enhancer function : | In addition, a significant increase in the pro-inflammatory cytokine (IL-1? and TNF-?) levels was observed in rats after GSK 126 treatment, and IL-1? administration increased seizure severity, suggesting that the inflammatory response was involved in the regulation of seizure development by EZH2. |
Enhancer function experiment: | Immunohistochemical staining |
Enhancer function experiment description: |
In addition, a significant increase in the pro-inflammatory cytokine (IL-1? and TNF-?) levels was observed in rats after GSK 126 treatment, and IL-1? administration increased seizure severity, suggesting that the inflammatory response was involved in the regulation of seizure development by EZH2. |
SNP ID: | -- |
GeneName | Pathway Name | Source | Gene Number |
---|